Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
Abstract Objective To assess the factors associated with the use of active surveillance (AS) in NCCN favourable intermediate‐risk (FIR) prostate cancer (PCa) patients who received the 17‐gene Genomic Prostate Score (GPS) assay. Material and Methods Contemporary data were collected from academic and...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Wiley
2025-03-01
|
| Rangatū: | BJUI Compass |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1002/bco2.494 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|